Sandoz Invests In New Biosimilar Manufacturing Facility - Healthcare
On July 20, 2023, Sandoz announced that it plans to invest approximately $90 million to build a Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026.
Slovenia General Lendava Lendva Development Center Biosimilar Technical Claired Abreu Hayling Chief Scientific Officer
Source: mondaq.com